SWI/SNF-deficient tumors of the central nervous system: An update

5Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant tumor of the central nervous system characterized by biallelic inactivation of SWI/SNF chromatin remodeling complex members SMARCB1/ INI1 or (rarely) SMARCA4/BRG1. Most high-grade central nervous system lesions showing loss of nuclear SMARCB1 or SMARCA4 protein expression can indeed be categorized as AT/RT. However, some high-grade lesions have been identified, whose clinical and/or molecular features justify separation from AT/RT. Furthermore, other recently described tumor types such as desmoplastic myxoid tumor, SMARCB1-mutant, and low-grade diffusely infiltrative tumor, SMARCB1-mutant, may even manifest as low-grade lesions. Here, we review recent developments in the definition of the molecular landscape of AT/RT and give an update on other rare high- and low-grade SWI/SNF-deficient central nervous system tumors.

Cite

CITATION STYLE

APA

Hasselblatt, M., Kool, M., & Frühwald, M. C. (2024). SWI/SNF-deficient tumors of the central nervous system: An update. Clinical Neuropathology, 43(1), 2–9. https://doi.org/10.5414/NP301594

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free